US Broker Ratings

HCA Healthcare, Inc. (HCA) Stock Report: Navigating Growth in the Healthcare Sector

HCA Healthcare, Inc. (NYSE: HCA), a giant in the medical care facilities industry, continues to be a focal point for investors seeking opportunities within the healthcare sector. With a market..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Analyzing Its 16.86% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) is a rising star in the healthcare sector, particularly within the biotechnology industry. Based in London, United Kingdom, this clinical-stage biopharmaceutical company is making waves..

Waystar Holding Corp. (WAY) Stock Analysis: A 47.59% Potential Upside That Investors Shouldn’t Overlook

Waystar Holding Corp. (NASDAQ: WAY) is gaining significant attention from investors, particularly those interested in the healthcare sector’s intersection with technology. Headquartered in Lehi, Utah, Waystar specializes in cloud-based solutions..

Align Technology, Inc. (ALGN) Stock Analysis: Navigating Growth in the Healthcare Sector with a 4.55% Upside

Align Technology, Inc. (NASDAQ: ALGN) stands as a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry. Based in Tempe, Arizona, the company is known..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Growth Amidst a 19.4% Revenue Surge

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, is gaining investor attention with its robust 19.4% revenue growth, positioning itself as a compelling option in the medical..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 43.55% Upside Potential in the Diagnostics & Research Sector

IQVIA Holdings, Inc. (NYSE: IQV) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $28.21..

Masimo Corporation (MASI) Stock Analysis: Navigating Opportunities in a Volatile Market

Masimo Corporation (MASI), a prominent player in the healthcare sector’s medical devices industry, has been capturing investor attention with its diverse portfolio of innovative patient monitoring technologies and automation solutions...

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech with a 59.42% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA) presents a compelling opportunity for investors seeking exposure to the biotechnology sector, specifically within the realm of plasma-derived biologics. With a market capitalization of $3.84..

STERIS plc (STE) Investor Outlook: Analyzing a 12.21% Potential Upside with Robust Revenue Growth

STERIS plc (NYSE: STE) stands out in the competitive healthcare sector as a prominent player in the medical devices industry. With a sprawling market capitalization of $24.6 billion, STERIS offers..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 10.71% Upside Potential

Investors eyeing the healthcare sector might find GE HealthCare Technologies Inc. (NYSE: GEHC) an intriguing player, especially with its potential upside of 10.71%. As a prominent force in the medical..

Revvity, Inc. (RVTY) Stock Analysis: Potential Upside and Strategic Positioning in Diagnostics & Research

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers compelling prospects for investors seeking opportunities in the health sciences technology..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Evaluating a 14.55% Potential Upside in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a key player in the healthcare sector, stands out in the specialty and generic drug manufacturing industry. With a market cap of $5.02 billion, Lantheus..

Corcept Therapeutics (CORT): Investor Outlook and Potential 119% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, has captured the attention of investors with its promising pipeline and robust market position. With a market capitalization..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 13.71% Upside Potential in the Diagnostics & Research Sector

Qiagen N.V. (NASDAQ: QGEN), a prominent player in the diagnostics and research industry, continues to capture investor attention with its promising market positioning and potential upside. As a leading provider..

Insmed Incorporated (INSM) Stock Analysis: Unveiling a 29% Potential Upside Amidst Robust Revenue Growth

In the dynamic realm of biotechnology, Insmed Incorporated (NASDAQ: INSM) stands out with its promising pipeline and robust revenue growth. With a market capitalization of $35.17 billion, Insmed has captured..

Incyte Corporation (INCY) Stock Analysis: Examining the 5.7% Upside Potential Amid Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is capturing investor attention with its impressive revenue growth and potential upside. With a market capitalization of $20.16 billion,..

CVS Health Corporation (CVS) Stock Analysis: Strong Buy Ratings and 23.67% Potential Upside

CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, is currently stirring interest among investors with its robust analyst ratings and attractive growth potential. As a leader..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 74% Potential Upside in the Innovative Vaccine Sector

Vaxcyte, Inc. (PCVX) is generating significant attention in the biotechnology sector, largely due to its innovative approach to vaccine development and a notable potential upside of 74.52% based on current..

Encompass Health Corporation (EHC) Stock Report: Analyst Consensus Reveals 33.95% Upside Potential

Encompass Health Corporation (NYSE: EHC), a key player in the healthcare sector, has captured the attention of investors with its solid market presence and promising growth trajectory. This Birmingham, Alabama-based..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring Growth Potential with a 35.94% Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading name in the biotechnology industry, is capturing investor attention with its robust pipeline and significant growth potential. As a key player in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds